Lifecore Biomedical, Inc. LFCR Accounts Receivable, Allowance for Credit Loss
Accounts Receivable, Allowance for Credit Loss at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s accounts receivable, allowance for credit loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s accounts receivable, allowance for credit loss?
- Lifecore Biomedical, Inc. (LFCR) reported accounts receivable, allowance for credit loss of $998K in Q1 2026.
- What is the long-term trend for Lifecore Biomedical, Inc.'s accounts receivable, allowance for credit loss?
- Over 2 years (2023 to 2026), Lifecore Biomedical, Inc.'s accounts receivable, allowance for credit loss has grown at a 43.4% compound annual growth rate (CAGR), from $485K to $998K.